Centers for Medicare & Medicaid Services, Center for Medicare and Medicaid Innovation, Baltimore, MD.
Centers for Medicare & Medicaid Services, Center for Medicare and Medicaid Innovation, Baltimore, MD.
Adv Chronic Kidney Dis. 2022 Jan;29(1):24-29. doi: 10.1053/j.ackd.2021.12.001.
This article describes two new and complementary initiatives from the Center for Medicare and Medicaid Innovation at the Centers for Medicare & Medicaid Services-the ESRD Treatment Choices and Kidney Care Choices Models-which focus on Medicare beneficiaries with CKD and ESRD. These models, or time-limited tests, are aimed at testing whether modifying Medicare payment methodologies, while also rewarding certain clinical outcomes, will improve treatment and outcomes and reduce costs. Together, these initiatives comprise a major part of the larger federal effort to improve the lives of people with kidney disease. The goal of the ESRD Treatment Choices Model is to maintain or improve quality while reducing cost by incentivizing greater use of home dialysis and kidney transplantation. The model aims to do so by adjusting certain payments to nephrologists and other clinicians managing beneficiaries with ESRD (managing clinicians) and ESRD facilities selected to participate in the model. The Kidney Care Choices Model aims to maintain or improve quality while reducing cost through better coordination of care across a larger spectrum of kidney disease, focusing on beneficiaries with CKD stages 4 and 5 and ESRD, to delay the onset of ESRD and improve the transition for Medicare beneficiaries facing the prospect of dialysis. The Centers for Medicare & Medicaid Services is hopeful that these models will inform the future direction of payment policy for this critical Medicare population.
本文介绍了医疗保险和医疗补助服务中心(Centers for Medicare & Medicaid Services)下属的医疗保险和医疗补助创新中心(Center for Medicare and Medicaid Innovation)的两项新的、相辅相成的举措——慢性肾脏病(CKD)和终末期肾病(ESRD)治疗选择和肾脏护理选择模式。这些举措或限时试验旨在测试修改医疗保险支付方式,同时奖励某些临床结果,是否会改善治疗效果和结果并降低成本。这些举措共同构成了联邦政府为改善肾病患者生活而进行的更大规模努力的重要组成部分。ESRD 治疗选择模式的目标是通过激励更多地使用家庭透析和肾移植来维持或提高质量并降低成本。该模式旨在通过调整管理 ESRD 患者的肾病学家和其他临床医生(管理临床医生)以及选择参与该模式的 ESRD 设施的某些付款来实现这一目标。肾脏护理选择模式的目标是通过更好地协调更广泛的肾脏疾病护理来维持或提高质量并降低成本,重点关注 CKD 第 4 阶段和第 5 阶段和 ESRD 的患者,以延迟 ESRD 的发生并改善面临透析前景的医疗保险受益人的过渡。医疗保险和医疗补助服务中心希望这些模式将为这一关键的医疗保险人群的支付政策未来方向提供信息。